Maria-Elena Torres-Padilla

Maria-Elena Torres-Padilla

Auto-generated profile, based on publicly available information

Maria-Elena Torres-Padilla

Institute of Epigenetics and Stem Cells, Helmholtz Munich, Munich, Germany; Faculty of Biology, Ludwig-Maximilians Universität, Munich, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2017 in Nature Genetics
Verified
Journal Article
Closed access
JJJoanna W Jachowicz
Joanna W Jachowicz
XBXinyang Bing
Xinyang Bing
JPJulien Pontabry
Julien Pontabry
ABAna Bošković
Ana Bošković
OROliver J Rando
Oliver J Rando
MTMaria-Elena Torres-Padilla
Maria-Elena Torres-Padilla

18 December 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DRDiego Rodriguez-Terrones
Diego Rodriguez-Terrones
XGXavier Gaume
Xavier Gaume
TITakashi Ishiuchi
Takashi Ishiuchi
AWAmélie Weiss
Amélie Weiss
AKArnaud Kopp
Arnaud Kopp
MTMaria-Elena Torres-Padilla
Maria-Elena Torres-Padilla

7 September 2020 in Nature
Verified
Journal Article
Open access
PDF file
NRNikolaus Rajewsky
Nikolaus Rajewsky
GAGenevieve Almouzni
Genevieve Almouzni
SGStanislaw A. Gorski
Stanislaw A. Gorski
SAStein Aerts
Stein Aerts
IAIdo Amit
Ido Amit
TVThierry Voet
Thierry Voet
Here we describe the LifeTime Initiative, which aims to track, understand and target human cells during the onset and progression of complex diseases, and to analyse their response to therapy at single-cell resolution. This mission will be implemented through the development, integration and application of single-cell multi-omics and imaging, artificial intelligence and patient-derived experimental disease models during the progression from health to disease. The analysis of large molecular and clinical datasets will identify molecular mechanisms, create predictive computational models of disease progression, and reveal new drug targets and therapies. The timely detection and interception of disease embedded in an ethical and patient-centred vision will be achieved through interactions across academia, hospitals, patient associations, health data management systems and industry. The application of this strategy to key medical challenges in cancer, neurological and neuropsychiatric disorders, and infectious, chronic inflammatory and cardiovascular diseases at the single-cell level will usher in cell-based interceptive medicine in Europe over the next decade.

22 May 2019 in Nature
Verified
Journal Article
Closed access
PDF file
MBMáté Borsos
Máté Borsos
SPSara M. Perricone
Sara M. Perricone
TSTamás Schauer
Tamás Schauer
JPJulien Pontabry
Julien Pontabry
KLKim L. de Luca
Kim L. de Luca
JKJop Kind
Jop Kind

29 June 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
ABAdam Burton
Adam Burton
VBVincent Brochard
Vincent Brochard
CGCarmen Galan
Carmen Galan
ERElias R. Ruiz-Morales
Elias R. Ruiz-Morales
QRQuirze Rovira
Quirze Rovira
MTMaria-Elena Torres-Padilla
Maria-Elena Torres-Padilla

1 January 2021 in Genes & Development
Verified
Journal Article
Open access
PDF file
CHClara Hermant
Clara Hermant
MTMaria-Elena Torres-Padilla
Maria-Elena Torres-Padilla
Transposable elements (TEs) are genetic elements capable of changing position within the genome. Although their mobilization can constitute a threat to genome integrity, nearly half of modern mammalian genomes are composed of remnants of TE insertions. The first critical step for a successful transposition cycle is the generation of a full-length transcript. TEs have evolved cis-regulatory elements enabling them to recruit host-encoded factors driving their own, selfish transcription. TEs are generally transcriptionally silenced in somatic cells, and the mechanisms underlying their repression have been extensively studied. However, during germline formation, preimplantation development, and tumorigenesis, specific TE families are highly expressed. Understanding the molecular players at stake in these contexts is of utmost importance to establish the mechanisms regulating TEs, as well as the importance of their transcription to the biology of the host. Here, we review the transcription factors known to be involved in the sequence-specific recognition and transcriptional activation of specific TE families or subfamilies. We discuss the diversity of TE regulatory elements within mammalian genomes and highlight the importance of TE mobilization in the dispersal of transcription factor-binding sites over the course of evolution.